Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
about
Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.The epidemiology of venous thromboembolismThe association of smoking with venous thrombosis in women. A population-based, case-control studyLower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogensLack of strong effect modification by NFE2L2/CYP3A5/ABO of the risk of venous thrombosis associated with oral hormone therapySmoking, postmenopausal hormone therapy and the risk of venous thrombosis: a population-based, case-control studySystematic identification of trans eQTLs as putative drivers of known disease associationsABO genotype and risk of thrombotic events and hemorrhagic stroke.Conjugated estrogens for the treatment of menopausal symptoms: a review of safety data.The epidemiology of venous thromboembolism in the community.Diabetes mellitus, glycemic control, and risk of atrial fibrillation.A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data.Prevention and treatment of venous thromboembolism during HRT: current perspectives.Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study.Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.Formulations of hormone therapy and risk of Parkinson's disease.Delivery systems for hormone replacement therapy.Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis.Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study.Vascular effects of estrogenic menopausal hormone therapy.Menopausal hormone therapy and venous thromboembolism.The Risk of Venous Thromboembolism with Different Generation of Oral Contraceptives; a Systematic Review and Meta-Analysis.Venous thromboembolism: disease burden, outcomes and risk factors.Breast cancer recurrence risk in relation to antidepressant use after diagnosis.Prior hysterectomy and oophorectomy and incident venous thrombosis risk among postmenopausal women: a population-based, case-control study.Menopausal hormone therapy for vasomotor symptoms: balancing the risks and benefits with ultra-low doses of estrogen.Breast cancer recurrence in relation to antidepressant use.Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population.Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women.Venous thromboembolism in women.Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the Women's Health Initiative Hormone Therapy clinical trialsHormone therapies and venous thromboembolism: where are we now?Menopausal hormone therapy: examining cardiovascular and clinical impacts of treatment.Oral Contraceptives and HRT Risk of Thrombosis.The differential association of conjugated equine estrogen and esterified estrogen with activated protein C resistance in postmenopausal women.Hormone replacement treatment choices in complete androgen insensitivity syndrome: an audit of an adult clinicCross-sectional association of endogenous steroid hormone, sex hormone-binding globulin, and precursor steroid levels with hemostatic factor levels in postmenopausal women.Epidemiology of venous thromboembolism.The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.Risk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations.
P2860
Q24658109-6EE18400-197D-47FE-8F63-1149010E1797Q28067893-3E67F7E3-D9E3-4B89-A476-40959C50AFADQ28606831-C7941C69-7FEF-408B-9E7D-3BE137CF948FQ28607716-58D5A158-82E0-4645-9E43-52FFB12F3E29Q28652242-752172B0-DFAF-4B02-9A58-6DC914A15E8EQ28652245-1834ADE2-6007-4E7B-AEEC-452458A6468EQ28659854-390B7D5C-04F6-4953-86BB-1E920A149FEAQ30496759-7509E754-4F1D-4767-9566-5EC3A52B8A22Q30659580-B73787FD-FE56-419C-9A29-D39F84B6DE63Q33865646-30AA22E6-034B-408D-A634-25D807E505E0Q33959715-5C8CF84C-5B0D-4C33-A95B-999F5E558A7BQ34133879-1F2C8F97-5A57-4E80-A33D-332E050FCC0BQ34140721-A922DCEA-4CFD-4E18-B862-E702786FD5EEQ34288033-69604AA0-917E-4C64-B4BC-202C2807BD9BQ34375771-7498B900-4CCB-432F-9EF5-D57E7D70F20CQ34437648-6562BA41-26D1-4217-954A-39028C028C87Q34498227-BB272DFC-6243-476D-9858-003CCE4E8D03Q35037432-8611C8F6-BB7F-42EA-B677-3F295D55212BQ35166781-37B2733A-19D4-4FA7-A1A0-1CAFB5742C78Q35583311-A6EC4F97-0C65-4431-A191-BE27FFD5E909Q35903637-4643248C-14F5-4E64-B840-6E74594407BBQ36188259-8452D1E1-8514-454E-916A-0E42D12746A4Q36230821-0F5BD951-A588-424D-A23B-42E0FE25F06DQ36459134-542EC9C6-9D40-4B6E-AB5C-C65A9A78E045Q36515384-7C9BA783-8A62-4256-A94E-9652F0B70F16Q37016116-7DC871A3-C866-47FD-A72B-1FA8781D43C2Q37020150-927A52DB-E86D-4E1C-BCD3-A2E3A2245113Q37168763-29B12A67-219A-42EB-A7A3-C67A95B3B486Q37237180-9CCD1D01-E381-4759-8278-2EC993949530Q37238147-ECFD1D3B-E442-462E-8710-A7B3D2270883Q37273894-1824B765-DB3B-4F0E-9DEF-5E94C4758E8CQ37813184-875877B9-19C4-4B5F-AA2E-FD3BF2D7EDFFQ38106504-C5E198D9-B981-4F24-9C8F-D8E1D8B4FA01Q39066094-CA1C148E-A3B0-4714-BA45-C90DA60F1356Q39347912-2D59FE1B-E9B4-4BA9-AED1-5B35C3C15E56Q39373880-18085F35-F48F-4467-B2C1-3F33CB85E520Q40503693-62353BFC-B77C-46E2-9522-3C2BAB614778Q41667853-931904BA-F789-420F-832A-DAA63ED8EE26Q44735545-0FF8527C-0815-453F-B144-6749FE98620BQ45946884-20932FD8-BBB8-47E1-8CBB-F4F546D5CC6D
P2860
Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
@ast
Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
@en
Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
@nl
type
label
Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
@ast
Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
@en
Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
@nl
prefLabel
Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
@ast
Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
@en
Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
@nl
P2093
P356
P1476
Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
@en
P2093
Alex P Reiner
Eric B Larson
Frits R Rosendaal
Nicholas L Smith
Noel S Weiss
Rozenn N Lemaitre
Thomas Lumley
P304
P356
10.1001/JAMA.292.13.1581
P407
P577
2004-10-01T00:00:00Z